06:06:03 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2024-08-30 Kvartalsrapport 2024-Q2
2024-05-27 Ordinarie utdelning OBSRV 0.00 NOK
2024-05-24 Årsstämma 2024
2024-03-13 Bokslutskommuniké 2023
2023-11-22 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-30 Ordinarie utdelning OBSRV 0.00 NOK
2023-05-26 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Årsstämma 2022
2022-06-03 Kvartalsrapport 2022-Q1
2022-06-03 Ordinarie utdelning OBSRV 0.00 NOK
2022-03-29 Bokslutskommuniké 2021
2022-02-04 Extra Bolagsstämma 2022
2021-11-03 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-25 Ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 Årsstämma 2021
2021-05-12 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-11-03 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 Årsstämma 2020
2020-06-16 Extra Bolagsstämma 2020
2020-05-12 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019


ListaOAX Equities
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2022-09-09 09:15:08
Oslo, 9 September 2022 - Observe Medical ASA ("the Company" or "Observe
Medical"), is pleased to announce the appointment of Carsten Trygve Bøgh as
Chief Technology Officer (CTO), effective 2 October 2022. Mr. Bøgh has a long
-standing medtech career, having led several innovative product launches,
delivered impactful results, and reached value-inflection milestones for

"We are delighted to announce Carsten's appointment as CTO and welcome him to
the management team. He has a strong background working with innovative devices
and a proven track record of product launches and development. He brings an
invaluable combination of industry experience and a strategic vision that will
support the team through the next development phases and beyond," said Rune
Nystad, CEO of Observe Medical.

Carsten Trygve Bøgh added: "Having been introduced to the Observe Medical team
and what is already a strong and exciting portfolio of medtech products, I look
forward to joining the team at this exciting juncture. The medical technology
landscape is advancing, and I am confident that Observe Medical will grow
alongside it."

Mr. Bøgh brings more than 25 years of strategic leadership experience in
medtech. He joins Observe Medical from Fresenius Medical Care Global research
and development in Germany, the world's leading provider of products and
services for individuals with renal diseases, where he held the role of Senior
Vice President, Global Product Development. Under his leadership, three new
innovative dialysis Therapy Systems were launched in APAC/China, EMEA and the
US, and a new and innovative Dialyzer for improved performance and
biocompatibility. Mr. Bøgh also introduced the first App-based Nurse and
Caretaker Cloud-based IT platform, which increased efficiency and lowered clinic

Previously, he served as the Senior Vice President, Global Portfolio Management
at Fresenius Medical Care. Before joining Fresenius, he held senior management
positions at Oticon A/S, an innovative hearing aid manufacturer based in
Denmark. Mr. Bøgh holds an Engineering Technology Manager (ETM) degree from
Copenhagen University College and an Ms.Sc.EE, Medical Ultrasound from the
Technical University of Denmark.

For further information, please contact:

Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and
sells innovative medtech products for the global market. The Company is
committed to improving patient welfare and patient outcomes, improving clinical
data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales
and commercialization of its broad portfolio of medical technology products,
mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound
care, in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in
Narvik (Norway), Gothenburg (Sweden), Oulu (Finland), and Seattle (the US).
In addition, Observe Medical has a direct sale organization in the Nordics and
a distributor network internationally.

Further information is available at www.observemedical.com.